BSEInsider Trading / SAST2d ago · 30 Sept 2026, 05:16 pm

Intimation of Closure of Trading Window

Evoq Remedies Ltd · 543500

✦ AI Summary

Evoq Remedies Ltd has announced the closure of its trading window for all directors, promoters, designated persons, and insiders from October 1, 2026, until 48 hours after the declaration and publication of unaudited financial results for the half year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Evoq Remedies Ltd - 543500 - Closure of Trading Window

Attachments (1)

📄

3fbcb0e1-b988-4aaf-ad47-f32d69fc24a5.pdf

pdf

Download →
View document text
Evoq Remedies Limited CIN: L46209GJ2010PLC059692 Regd. Office: A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India – 380 060 E-mail: evoqremedies@gmail.com Website: www.evoqremedies.com Date: 30th September, 2026 BSE Limited Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400 001 Dear Sir / Ma’am, Subject: Intimation of Closure of Trading Window Ref: Security Id: EVOQ / Code: 543500 Pursuant to Clause 4 of Schedule B of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended and trading restrictions placed by the Company's Code of Practices, Procedure and Conduct to Regulate, Monitor and Report Trading by Insiders (‘the Code’), we hereby inform that the Trading Window for purchasing, selling or dealing in the Equity Shares of the Company, will remain closed for all Directors, Promoters, Designated Persons and Insiders of the Company from Thursday, 1st October, 2026 till 48 hours after the declaration and publication of Unaudited Financial Results for the Half Year ended on 30th September, 2026. Please take note of the same and oblige. Thanking You. For, Evoq Remedies Limited Dipti Narayan Mundra Resolution Professional IBBI/IPA-001/IP-P-02845/2023-2024/14366